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doi:10.1016/j.kjms.2010.08.005Abstract Nasopharyngeal carcinoma (NPC) is prevalent in Taiwan and is characterized by
a high frequency of nodal metastasis. The most common organs with distal metastases are
the bones, lungs, and liver, with extremely rare cases to the pericardium. Herein, we report
a rare case with NPC who presented with dyspnea and orthopnea. Serial studies, including peri-
cardial biopsy, revealed NPC with pericardial metastasis and pericardial effusion. The tumor
cells of both the original and metastatic tumors were positive for EpsteineBarr virus by in situ
hybridization. This is the first histologically confirmed case of NPC with pericardial metastasis.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Nasopharyngeal carcinoma (NPC) occurs in Taiwan with an
annual incidence of 5.4 per 100,000. It is clinically distinct
from the other malignant head and neck cancers by a higher
rate of nodal metastasis, a unique histopathology
(frequently undifferentiated or lymphoepithelioma-like
carcinoma), and greater sensitivity to radio- and chemo-
therapy [1]. Bones, lungs, and liver are the most common
sites of distant metastases [2,3]. Pericardial metastasis is
extremely rare, with only one reported case so far, but
devoid of histolopathological confirmation [4]. Herein, weof Pathology, Chi-Mei Medical Ce
imei.org.tw (S.-S. Chuang).
vier Taiwan LLC. All rights reservpresent the case of a young adult man with NPC and biopsy-
proven pericardial metastasis.
Case presentation
In October 2004, a 25-year-old male patient was admitted
because of a gradual onset of shortness of breath with
orthopnea and exertional dyspnea for a few days. Physical
examination revealed mild fever, tachypnea, and jugular
vein engorgement. Chest radiograph showed bilateral lung
nodules and cardiomegaly. Laboratory examination showed
mild anemia (hemoglobin at 10.3 g/dL) with normalnter, 901 Chung-Hwa Road, Yung-Kang District, Tainan 710, Taiwan.
ed.
Figure 1. A computed tomography scan of chest with
contrast enhancement shows pericardial effusion with peri-
cardial thickening.
290 S.-W. Chen et al.leukocyte and platelet counts and normal levels of
biochemistry. Echocardiography revealed a moderate
amount of pericardial effusion without collapse of the right
atrium or ventricle. Computed tomography (CT) scan of the
chest showed a large amount of pericardial effusion, peri-
cardium thickening, and some metastatic nodules in bilat-
eral lung fields (Fig. 1). Pericardiectomy with biopsy wasFigure 2. Photomicrographs of (A and C) nasopharyngeal and (B a
cohesive sheet and islands of tumor cells with a rich lymphoid strom
situ hybridization (EBV-ISH; arrows). (B) The pericardial biopsy sho
cells are also positive for EBV-ISH (arrows).performed, and a chest tube was inserted. The chest tube
was removed 12 days later when his condition improved,
and he was discharged on the same day. Two months later,
a follow-up chest CT scan showed minimal pericardial
effusion and progression of pulmonary metastasis. He
received four courses of palliative chemotherapy with
fluorouracil and leucovorin in early 2005. Unfortunately, he
died of progressive disease in late April 2005, 6 months
after pericardial biopsy and 43 months after the initial
diagnosis of NPC. An autopsy was not performed.
Tracing back his history, in June 2001, when the patient
was 22 years old, he suffered from right facial numbness for
a few days with deviation to the right side when protruding
his tongue. A CT scan of the head and neck showed a 3-cm
right nasopharyngeal tumor with upward invasion to the
right cavernous sinus and multiple enlarged lymph nodes in
the bilateral posterior cervical triangle and bilateral
carotid sheath spaces. Fibro-optic examination of the
nasopharynx with biopsy revealed an undifferentiated
carcinoma. Staging result was IVA (T4N2M0) according to
the criteria of the American Joint Committee of Cancer. He
achieved complete remission after concurrent chemo-
radiotherapy comprising cisplatin and 7,020 cGy of radia-
tion to the nasopharynx and upper neck, 6,660 cGy to the
cranium, and 5,940 cGy to the lower neck. Unfortunately,
in March 2003, he complained of back pain, and a bone
scan showed a bony metastasis at the thoracic spine. Hend D) pericardial biopsies. (A) The nasopharyngeal biopsy shows
a. (C) The tumor cells are positive for EpsteineBarr virus by in
ws similar cancer cell nests in a fibrotic stroma. (D) The tumor
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complete resolution of the lesion. A second bony relapse at
the spinal column and bilateral sacroiliac bone occurred in
July 2004, and he received additional 4,000 cGy of radiation
to the spine with, again, complete resolution.
Review of the original nasopharyngeal biopsy showed an
undifferentiated carcinoma comprising sheets and islands
of polygonal tumor cells admixed with small lymphocytes
(Fig. 2A). The pericardial specimen demonstrated a similar
histopathology with islands of undifferentiated tumor cells
with stromal fibrosis (Fig. 2B). In situ hybridization for the
EpsteineBarr virus (EBV)-encoded mRNA was performed in
an autostainer (Bond MAX; Vision BioSystems Ltd., Mount
Waverley, Australia) using a polymer-based detection
system (Bond Polymer Refine Detection; Vision BioSystems
Ltd.) with an EBV-specific probe (Bond ISH EBER Probe;
Vision BioSystems Ltd.) and 3,3’-diaminobenzidine as
chromogen. The tumor cells in both the original NPC and
the pericardial metastasis revealed positive nuclear signals
(Figs. 2C and 2D).
Discussion
NPC is notorious for its predilection for both lymphatic and
hematogeneous spread. It is clinically distinct from cancers
of the oral cavity and oropharynx by a high frequency (up to
80e90%) of regional nodal metastasis at presentation, with
bilateral involvement in approximately half of the patients
[1]. Furthermore, distant metastasis is common [2,3].
Reviewing 256 patients with NPC, Ahmad and Stefani [2]
found a 36% overall incidence of distant metastases and
51% in the autopsies. Bones (48%), distant lymph nodes (43%),
liver (36%), and lungs (31%) were the most common sites of
distant metastases, whereas liver was the most common site
in autopsies [2]. In a retrospective study of 90 patients from
Hong Kong who developed distant metastases after radical
radiotherapy for NPC, Leung et al. [3] found that the skeleton
was the commonest site of distant metastases, and the
median survival of all patients with distant metastases was 8
months. Liu et al. [5] reported that the prognostic factors
affecting the outcome of NPC patients in Taiwan included
tumor stage, nodal status, and cumulative radiation dose to
the primary tumor, and furthermore, distant metastasis was
the main prognostic factor on survival.
Primary tumors of the heart and pericardium are
extremely rare, whereas secondary or metastatic pericardial
tumors are not uncommon, with most of the secondarytumors arising from primary cancers of the lung, breast,
stomach and esophagus, and hematological malignancies
[6]. Pericardial metastases have been reported from rare
primary cancer sites/organs, such as oral mucosa, uterine
cervix, urinary bladder, and sigmoid colon [7e10]. NPC is
extremely rare as the primary cancer with pericardial
metastasis. To the best of our knowledge, there is only one
such case in the English literature in which the patient pre-
sented with cardiac tamponade; however, the diagnosis was
made clinically without tissue proof [4]. Our patient is the
first case of NPC with pericardial metastases confirmed by
pericardial biopsy, and our diagnosis was further supported
by EBV in situ hybridization.
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